Announcements Trials
Browse Landscape

Phase

Phase 3 24Phase 2 16Phase 4 6Phase 1/2 3Phase NA 2Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

Mammography 12Radiofrequency Ablation 9Blood Specimen Collection 9Standard of Care 8Drug Delivery Systems 8Colonoscopy 8Uterine Myomectomy 6Robotic Surgical Procedures 6Colposcopy 6Biopsy 6Proton Therapy 5Inositol 5Cryosurgery 5Therapeutics 4Surgical Procedures, Operative 4Radiotherapy 4Leukapheresis 4Food 4Drug Therapy 4Cryotherapy 4Cisplatin 4CF regimen 4Brachytherapy 4pegylated granulocyte colony-stimulating factor 3exemestane 3epigallocatechin gallate 3Uterine Artery Embolization 3Sunitinib 3Paclitaxel 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Leuprolide × Clear all
NCT03662958 2018-09-10

Comparison of a Novel Leuprolide With Market Leuprolide

Lee's Pharmaceutical Limited

Phase NA Unknown
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT00056654 2008-09-17

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Abbott

Phase NA Completed
164 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡